Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, techmover, bz777, gentle09, whento, HighYieldStocks
Search This Board: 
Last Post: 12/15/2017 8:04:29 PM - Followers: 450 - Board type: Free - Posts Today: 92



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#62579  Sticky Note ARYC Potential revenue streams partial list: whento 12/14/17 12:06:33 PM
#62575  Sticky Note Good Overview for all new investors: bz777 12/14/17 11:53:56 AM
#62553  Sticky Note Ten reasons NOT to invest in ARYC rh22 12/14/17 11:04:40 AM
#61908  Sticky Note For new investors: Please DD Silicon Valley biotech, gentle09 12/05/17 06:21:44 PM
#59181  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 10/26/17 12:28:09 PM
#62719   .0029 was the close on December 16, 2016. UndervaluedStocks 12/15/17 08:04:29 PM
#62718   I got in a little over a month 0cash 12/15/17 08:01:25 PM
#62717   Up 210% over the past year is a SK510 12/15/17 06:33:55 PM
#62716   Despite the volume it was a great trading ROSECITY 12/15/17 06:33:50 PM
#62715   Take a good look at Illumina and tell UndervaluedStocks 12/15/17 06:19:47 PM
#62714   Everything is pointing in that direction, Starlight UndervaluedStocks 12/15/17 06:18:26 PM
#62713   Agree. I think by a company starting with TravO 12/15/17 05:38:37 PM
#62712   U got insider info that the company is Starlight84 12/15/17 05:35:26 PM
#62711   This audit must be precise and extremely accurate....why? UndervaluedStocks 12/15/17 05:27:57 PM
#62710   The point is you are impatient. If you TravO 12/15/17 05:11:39 PM
#62709   Look at the chart. PPS is steadily increasing UndervaluedStocks 12/15/17 05:00:57 PM
#62707   Ok ok you are right, it's trading just jrsh 12/15/17 03:50:55 PM
#62705   Same here, and I'm up substantially on my bz777 12/15/17 03:44:42 PM
#62704   an after hours present would be nice. but whento 12/15/17 03:44:19 PM
#62703   I agree tech, I ve been collecting shares Penny Traders Club 12/15/17 03:44:02 PM
#62702   Look, fact is it is trading miserable and jrsh 12/15/17 03:43:48 PM
#62701   Like I said you know for a fact whento 12/15/17 03:38:58 PM
#62700   Have the rest of the week been much better? jrsh 12/15/17 03:35:22 PM
#62699   Ridiculous again. just based on today, that's all whento 12/15/17 03:30:49 PM
#62698   It is just one side of the equation jrsh 12/15/17 03:30:41 PM
#62697   Hell yes! When you see products being shipped techmover 12/15/17 03:27:55 PM
#62696   Just look at the volume call that accumulation??? jrsh 12/15/17 03:27:34 PM
#62695   Really!!! Just seeing some products shipping is enough for you??? jrsh 12/15/17 03:25:59 PM
#62694   Bullshit too! I've seen products going out the techmover 12/15/17 03:23:27 PM
#62693   Ridiculous. How do you know who has or whento 12/15/17 03:23:01 PM
#62691   Well hells bells! I bought in a year techmover 12/15/17 03:14:03 PM
#62690   Agree, and well said Penny Traders Club 12/15/17 02:56:14 PM
#62689   Look, I have bought in about a year jrsh 12/15/17 02:55:17 PM
#62688   Not much to wonder about. People. Ought in TravO 12/15/17 02:47:11 PM
#62687   Ever wondered that even the thrilled ones aren't buying??? jrsh 12/15/17 02:41:28 PM
#62686   Exactly. Doesn't make sense how anyone would not SK510 12/15/17 02:33:27 PM
#62685   With sales like that hard to disagree Penny Traders Club 12/15/17 02:29:04 PM
#62684   Not a bad number I'd say. SK510 12/15/17 02:28:16 PM
#62683   This stock is gonna blow once current ???? SK510 12/15/17 02:27:44 PM
#62681   Arrayit provides additional samples for $2.9 million microarray UndervaluedStocks 12/15/17 02:21:57 PM
#62680   Link to their products: UndervaluedStocks 12/15/17 02:21:26 PM
#62679   @Arrayit on Twitter UndervaluedStocks 12/15/17 02:20:51 PM
#62678   Arrayit signs $27.1 million term sheet for microarray UndervaluedStocks 12/15/17 02:20:18 PM
#62677   NEW tweet...Arrayit reports microarray hardware sale shipping request HighYieldStocks 12/15/17 02:04:27 PM
#62676   NEW tweet...Arrayit-USDA food safety testing team invited to HighYieldStocks 12/15/17 02:02:02 PM
#62675   Our current situation: UndervaluedStocks 12/15/17 01:59:11 PM
#62674   Nice bid stacking at.0074 I hope they don’t Penny Traders Club 12/15/17 01:47:53 PM
#62672   Oh, OK got it. Same here, happy to UndervaluedStocks 12/15/17 01:42:30 PM
#62671   I'll pass thank you - happy to hold Delsurfer 12/15/17 01:33:00 PM
#62670   Seems that way. time will tell . tick tock. whento 12/15/17 01:30:12 PM
#62669   NEW tweet...Arrayit reports high volume microarray consumables request HighYieldStocks 12/15/17 01:28:27 PM
#62668   Time of cheap shares declining...doors going to shut HighYieldStocks 12/15/17 01:28:02 PM
#62667   No one selling 7’s anymore ....whack those 9’s Del!! UndervaluedStocks 12/15/17 01:24:06 PM
#62666   The question in my mind is whether Iconic Delsurfer 12/15/17 01:18:24 PM
#62665   Too bad for them. Can’t change a contract UndervaluedStocks 12/15/17 01:18:20 PM